MDxHealth Q3 2023 Gaap EPS $(0.04) Beats $(0.19) Estimate, Sales $19.35M Beat $17.99M Estimate
Portfolio Pulse from saritha@benzinga.com
MDxHealth reported Q3 2023 GAAP EPS of $(0.04), beating the estimate of $(0.19) by 78.95%. This is a 20% increase over the same period last year. The company also reported quarterly sales of $19.35M, beating the estimate of $17.99M by 7.56%, a 73.48% increase over the same period last year.
November 08, 2023 | 10:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MDxHealth's Q3 2023 results exceeded expectations with EPS and sales beating estimates by 78.95% and 7.56% respectively. This indicates a strong financial performance.
MDxHealth's Q3 2023 results exceeded analyst estimates, indicating a strong financial performance. The EPS beat estimates by 78.95%, and sales beat estimates by 7.56%. This positive news is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100